Ubiquitin signatures on aggregating proteins in neurodegeneration
Open Access
- 22 December 2025
- journal article
- review article
- Published by Portland Press Ltd. in Essays in Biochemistry
- Vol. 69 (05)
Abstract
The aberrant accumulation of misfolded proteins marked by cellular dysfunction and progressive neuronal loss is the hallmark of neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis. This review examines the pivotal role of ubiquitin modifications in altering the fate of aggregation-prone proteins such as tau, α-synuclein, mutant huntingtin, TAR DNA-binding protein 43 and superoxide dismutase 1. The ubiquitin signatures identified by their linkage types, chain architectures and site specificities emerge as a complex regulatory language that influences the clearance, aggregation or cellular propagation of these aggregating proteins. The dysregulation of other components of the ubiquitin association pathways, such as impaired E3 ligases and deubiquitinases, also contributes to the inefficient protein disposal and disease progression. Understanding how ubiquitin signatures alter the spatiotemporal dynamics of aggregating proteins is critical for advancing our knowledge of disease biology. Here, we focus on the role of ubiquitin modifications and their associated regulators affecting protein fate and neurotoxicity, and highlight the current therapeutic strategies targeting the degradation of aggregating proteins to uncover potential avenues for treating neurodegenerative diseases.Keywords
This publication has 143 references indexed in Scilit:
- Untangling the Complexity and Impact of Tau Protein UbiquitinationChemBioChem, 2024
- Site‐Specific Ubiquitination of Tau Amyloids Promoted by the E3 Ligase CHIPAngewandte Chemie International Edition, 2023
- Heat shock proteins: Biological functions, pathological roles, and therapeutic opportunitiesMedcomm, 2022
- Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's DiseaseProteomics, 2018
- Discovery of Small Molecules that Induce the Degradation of HuntingtinAngewandte Chemie International Edition, 2017
- α‐Synuclein oligomers and clinical implications for Parkinson diseaseAnnals of Neurology, 2012
- Hsp90 and Client Protein Maturation2011
- Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutationsAnnals of Neurology, 2007
- In Situ and in Vitro Study of Colocalization and Segregation of α-Synuclein, Ubiquitin, and Lipids in Lewy BodiesExperimental Neurology, 2000
- Lewy bodies are ubiquitinatedActa Neuropathologica, 1988